1. Bevacizumab effect on viability of free groin flaps in rats
- Author
-
João Mamede, Manoel Odorico Moraes, Gabriel Pinheiro Furtado, and Francisco Vagnaldo Fechine
- Subjects
bevacizumab ,surgical flaps ,free tissue flaps ,tissue survival ,rats ,microsurgery ,Surgery ,RD1-811 - Abstract
Introduction: Bevacizumab is among the most frequently used drugs in cancer treatment. There is evidence that some anti-angiogenic drugs reduce flap survival, but it is unclear whether this applies to Bevacizumab. We investigated the effect of Bevacizumab on the viability of free flaps in rats. Methods: The animals were randomly assigned to one of three groups. The Graft group received intravascular saline and was submitted to a full-thickness skin graft. The Flap-Saline and the Flap-BVZ groups underwent a free groin flap after receiving, respectively, intravascular saline solution or intravascular administration of Bevacizumab. Results: The Graft group showed a lower percentage of the viable area (22.81%) relative to the Flap-Saline (83.98%; p
- Published
- 2023
- Full Text
- View/download PDF